Citadel Advisors’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $999K | Sell |
325,389
-668,231
| -67% | -$2.05M | ﹤0.01% | 3303 |
|
|
2025
Q1 | $1.92M | Buy |
993,620
+831,301
| +512% | +$1.6M | ﹤0.01% | 2635 |
|
|
2024
Q4 | $607K | Buy |
162,319
+24,580
| +18% | +$91.9K | ﹤0.01% | 3801 |
|
|
2024
Q3 | $674K | Sell |
137,739
-90,398
| -40% | -$442K | ﹤0.01% | 3485 |
|
|
2024
Q2 | $1.71M | Sell |
228,137
-295,606
| -56% | -$2.22M | ﹤0.01% | 2582 |
|
|
2024
Q1 | $13M | Buy |
+523,743
| New | +$13M | ﹤0.01% | 1136 |
|